Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Reprogram ; 14(2): 112-22, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22339199

RESUMEN

Distinct signaling pathways are reported to maintain pluripotency in embryo-derived stem cells. Mouse embryonic stem cells (ESCs) respond to leukemia inhibitory factor (LIF) and bone morphogenetic protein (BMP)-mediated activity, whereas human ESCs depend upon Fibroblast growth factor (FGF) and activin signaling. In the majority of mammals investigated, however, the signals that support stem cell pluripotency are not well defined, as is evident by the persistent difficulties in maintaining authentic stable ESC lines. Induction of pluripotency by transcription factor-mediated reprogramming could provide an alternative way to produce ESC-like cells from nonpermissive species, and facilitate identification of core ESC signaling requirements. To evaluate the effectiveness of this approach in pigs, we transduced porcine foetal fibroblasts with retroviruses expressing Oct4, Sox2, Klf4, and c-Myc, and maintained the resulting cultures in medium containing either LIF or FGF2. Alkaline phosphatase positive colonies with compact, mouse ESC-like morphology were preferentially recovered using serum-free medium supplemented with LIF. These cell lines expressed the endogenous stem cell transcription factors, OCT4, NANOG, and SOX2, and the cell surface marker SSEA-4, consistent with acquisition of an undifferentiated state. However, restricted differentiation potential, and persistent expression of retroviral transgenes indicated that reprogramming was incomplete. Interestingly, LIF activated both the transcription factor STAT3 and its target gene SOCS3, and stimulated cell growth, indicating functional coupling of the signaling pathway in these cells. This demonstration of LIF-dependence in reprogrammed pig cells supports the notion that the connection between LIF/STAT3 signaling and the core regulatory network of pluripotent stem cells is a conserved pathway in mammals.


Asunto(s)
Reprogramación Celular/fisiología , Células Madre Embrionarias/metabolismo , Fibroblastos/metabolismo , Factor Inhibidor de Leucemia/metabolismo , Animales , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Diferenciación Celular/fisiología , Células Cultivadas , Reprogramación Celular/efectos de los fármacos , Reprogramación Celular/genética , Células Madre Embrionarias/efectos de los fármacos , Células Madre Embrionarias/fisiología , Feto/citología , Feto/metabolismo , Feto/fisiología , Fibroblastos/efectos de los fármacos , Fibroblastos/fisiología , Perfilación de la Expresión Génica , Células HEK293 , Humanos , Factor 4 Similar a Kruppel , Factor Inhibidor de Leucemia/genética , Factor Inhibidor de Leucemia/farmacología , Factor Inhibidor de Leucemia/fisiología , Ratones , Ratones Endogámicos NOD , Ratones SCID , Análisis por Micromatrices , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Transducción de Señal/fisiología , Porcinos , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA